NL6901341A - - Google Patents

Info

Publication number
NL6901341A
NL6901341A NL6901341A NL6901341A NL6901341A NL 6901341 A NL6901341 A NL 6901341A NL 6901341 A NL6901341 A NL 6901341A NL 6901341 A NL6901341 A NL 6901341A NL 6901341 A NL6901341 A NL 6901341A
Authority
NL
Netherlands
Application number
NL6901341A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6901341A publication Critical patent/NL6901341A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/004Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa
    • C07J7/0045Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
NL6901341A 1968-01-29 1969-01-28 NL6901341A (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB456968A GB1260464A (en) 1968-01-29 1968-01-29 11beta-HALO-STEROIDS

Publications (1)

Publication Number Publication Date
NL6901341A true NL6901341A (enExample) 1969-07-31

Family

ID=9779625

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6901341A NL6901341A (enExample) 1968-01-29 1969-01-28

Country Status (6)

Country Link
CH (1) CH547789A (enExample)
DE (1) DE1904324A1 (enExample)
DK (1) DK130646B (enExample)
FR (1) FR2000923A1 (enExample)
GB (1) GB1260464A (enExample)
NL (1) NL6901341A (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052929A1 (enExample) * 1969-06-04 1971-04-16 Bristol Myers Co

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2052929A1 (enExample) * 1969-06-04 1971-04-16 Bristol Myers Co

Also Published As

Publication number Publication date
FR2000923A1 (enExample) 1969-09-19
DK130646C (enExample) 1975-08-25
DK130646B (da) 1975-03-17
CH547789A (de) 1974-04-11
DE1904324A1 (de) 1969-09-11
GB1260464A (en) 1972-01-19

Similar Documents

Publication Publication Date Title
AU5506869A (enExample)
AU5184069A (enExample)
AU6171569A (enExample)
DK130646C (enExample)
AU4811568A (enExample)
AU3789668A (enExample)
AU3224368A (enExample)
AU4744468A (enExample)
BE711859A (enExample)
BE709415A (enExample)
BE727762A (enExample)
BE727753A (enExample)
BE727653A (enExample)
BE727467A (enExample)
BE727304A (enExample)
BE727058A (enExample)
BE726731A (enExample)
BE726184A (enExample)
BE725572A (enExample)
BE725028A (enExample)
BE723052A (enExample)
BE721655A (enExample)
BE720676A (enExample)
BE709496A (enExample)
BE709484A (enExample)